Pharmacology

Top Story

Mydayis improves ADHD, functioning in adults

Mydayis improves ADHD, functioning in adults
September 17, 2017

NEW ORLEANS — Data presented here indicated efficacy and safety of Mydayis, a once-daily mixed salts of a single-entity amphetamine product, for ADHD in adults.

“It was very important for us to pull all the studies together that we’ve studied in the adult population. The first one is the efficacy and safety poster comparing Mydayis [Shire] to placebo in three of our randomized controlled studies and one long-term study to allow everyone to assess the short-term efficacy and the long-term 52-week efficacy of Mydayis compared to placebo,” Manisha Madhoo, MD, vice president, Global Medical Affairs, Neuroscience, Shire, told Healio.com/Psychiatry. “The conclusions of these studies are that ... Mydayis is significantly clinically superior to placebo in the [ADHD Rating Scale] and [Clinical Global Impressions-Improvement]. In the global clinical function scale, Mydayis compared to placebo is superior.”

Meeting News

Two studies show promising results for NKTR-181

September 15, 2017
Patients receiving the opioid analgesic NKTR-181 had reduced back pain and exhibited low rates of opioid withdrawal, compared their counterparts who took a placebo…
Meeting News

Lasmiditan provides faster migraine pain relief vs. placebo

September 13, 2017
Compared with placebo, lasmiditan reduced migraine pain and symptoms after 2 hours for most patients with at least moderate disability, according to findings presented…

Experts suggest ways for PCPs to identify, manage patients’ pain

September 13, 2017
With the CDC stating that the opioid epidemic claims 91 lives per day and at least one study suggesting that chronic opioid use can be triggered in as little 3 days, the…
More Headlines »
CDR CME CNE CPE

Back to the Future: Clinical Experience with and Access to Lipid-Lowering Agents of the Past, Present, and Future

This activity is supported by educational funding provided by Amgen and Sanofi US and Regeneron Pharmaceuticals.

With each passing year we gain new insight and understanding around the clinical utilization of lipid-lowering…
More »
GI Bookshelf

Chapter 29: Management of Crohn’s Disease in the Ileal-Pouch Anal Anastomosis

From Crohn's Disease: The Complete Guide to Medical Management
More »
Resource Centers
American Association of Nurse Practitioners National Conference

American Association of Nurse Practitioners National Conference

Video
Meeting News Coverage

VIDEO: Recognizing and managing depression in pregnant women can begin in primary care

May 6, 2016
More »
Advertisement
Advertisement